<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404594/" ref="ordinalpos=4167&amp;ncbi_uid=7445784&amp;link_uid=PMC4404594" image-link="/pmc/articles/PMC4404594/figure/Fig1/" class="imagepopup">Figure 1.  From: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy. </a></div><br /><div class="p4l_captionBody">Model of CIP2A involvement in the EGFR-RAS signaling pathways. ETS1 mediates CIP2A overexpression in human cancers with increased EGFR-MEK-ERK pathway activity. A positive feedback loop of CIP2A and MEK/ERK signaling pathways is shown.</div></div>